Tenderwize
Retour à la recherche

Pharmaceutical supply for OSI BarrualdeGaldakao residences

OSAKIDETZA - Servicio Vasco de Salud - Organización Central·Vitoria-Gasteiz, Spain·EUR 6M·Expired · Aug 07, 2026·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
High value
Titre original de l'avis

Spain – Pharmaceutical products – Suministro de medicamentos a la OSI BarrualdeGaldakao para dar cobertura a las plazas actuales de las residencias ubicadas en la comunidad autónoma de Euskadi (CAE)

67/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

67 / 100

Complexité

58 / 100

Facteurs de risque

The structured data deadline time (10:00 UTC) and XML notice end time (12:00 +02:00) may reflect the same moment, but t...

The XML notice contains several formula-based award criteria not fully reflected in the structured data, so the scoring...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Pays
Espagne
CPV
33600000 - Pharmaceutical products
Date limite
Aug 07, 2026
Valeur estimée
EUR 6M

Aperçu

Moderate opportunity

Faits clés

  • EUR 6M estimated value
  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of pharmaceutical products/medicines for OSI BarrualdeGaldakao.
  • Coverage of current places in residences located in the Basque Country (CAE).
Afficher le résumé complet

Open supply contract for pharmaceutical products for OSI BarrualdeGaldakao, covering current places in residences in the Basque Country (CAE). One lot is shown. The contract value is EUR 6,047,141.38 and the duration is 2 years, with 2 planned extensions. Electronic submission is required. The notice and XML provide some award and eligibility information, but no procurement document text was provided beyond the TED XML notice, so confidence is moderate.

Risques

The structured data deadline time (10:00 UTC) and XML notice end time (12:00 +02:00) may reflect the same moment, but t...

The XML notice contains several formula-based award criteria not fully reflected in the structured data, so the scoring...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Variants are not allowed.

Administrative

  • Electronic submission is required.
  • Submission deadline is 2026-08-07 10:00 UTC from the structured data; XML notice shows 2026-08-07 12:00 local time, so time zone interpretation should be checked.

Critères d'attribution

Lot 1

Cost criterion: Price, weight 46, code poi-exa — 46%

Acheteur

Localisation

Vitoria-Gasteiz, ESP

Profil acheteur

Ouvrir le profil

Identifiant

S5100023J

Activité

Health

Lots (1)

LOT-0001

Pharmaceutical supply for OSI BarrualdeGaldakao residences

Supply of medicines to OSI BarrualdeGaldakao to cover current places in residences located in the Basque Country (CAE). The lot is a supplies contract with a 2-year duration and is to be performed in Spain, specifically ES213.

SuppliesEU fundedElectronic submission

EUR 6M

Valeur estimée

Localisation

ES213, Spain

Durée

2 YEAR

Catégorie

Pharmaceutical products

Critères d'attribution

Cost

Date limite

Expired Aug 07, 2026

Détails de la procédure

Date de publication
07 Jul 2026
Langues
Spanish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
470388-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Dec 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30